Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication
Mingjing He, Zhuan Zhou, George Y. Wu, et al.
Pharmacology & Therapeutics (2017) Vol. 177, pp. 96-107
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4002-4002
Open Access | Times Cited: 218
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
Jinfang Zhang, Fabin Dang, Junming Ren, et al.
Trends in Biochemical Sciences (2018) Vol. 43, Iss. 12, pp. 1014-1032
Open Access | Times Cited: 182
Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors
Shiyao Chen, Yunqi Liu, Huchen Zhou
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4546-4546
Open Access | Times Cited: 103
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 93
Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
Jente van Staalduinen, D.A. Baker, Peter ten Dijke, et al.
Oncogene (2018) Vol. 37, Iss. 48, pp. 6195-6211
Closed Access | Times Cited: 153
Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1
Dan Zhu, Ruidan Xu, Xinping Huang, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 6, pp. 1773-1789
Open Access | Times Cited: 123
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation
Yunhai Li, Jing Huang, Beilei Zeng, et al.
Cancer Letters (2018) Vol. 430, pp. 109-122
Closed Access | Times Cited: 105
USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK/MAPK signaling pathway
Hongze Sun, Baochi Ou, Senlin Zhao, et al.
EBioMedicine (2019) Vol. 48, pp. 236-247
Open Access | Times Cited: 101
m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis
Weimei Huang, Zhixun Li, Yinghui Wu, et al.
Translational Oncology (2022) Vol. 27, pp. 101576-101576
Open Access | Times Cited: 58
piRNA-1742 promotes renal cell carcinoma malignancy by regulating USP8 stability through binding to hnRNPU and thereby inhibiting MUC12 ubiquitination
Wentao Zhang, Zongtai Zheng, Keyi Wang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 6, pp. 1258-1271
Open Access | Times Cited: 22
Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review
Zaigang Zhou, Haoxiang Wang, Jie Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127911-127911
Closed Access | Times Cited: 22
Exploring Ubiquitin-Specific Proteases as Therapeutic Targets in Glioblastoma
Vijaya Paul Samuel, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155443-155443
Closed Access | Times Cited: 8
Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity
Tao Qin, Bai Li, Xiaoyue Feng, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 80
Crosstalk in cancer resistance and metastasis
Saeed Norouzi, Mahmoud Gorgi Valokala, Fatemeh Mosaffa, et al.
Critical Reviews in Oncology/Hematology (2018) Vol. 132, pp. 145-153
Closed Access | Times Cited: 62
Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy
Keng Po Lai, Jian Chen, William Ka Fai Tse
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2548-2548
Open Access | Times Cited: 51
PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism
Yanjie Tan, Yi Jin, Xiang Wu, et al.
BMC Molecular Biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 53
Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma
Yu-Fei Cao, Lei Xie, Bei-Bei Tong, et al.
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 527-543
Open Access | Times Cited: 24
Deubiquitinase USP28 promotes the malignant progression and radio-resistance of hepatocellular carcinoma by stabilizing WDHD1
Wen Wu, Zhenhua Zhou, Chao Chen, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Deubiquitinating enzymes in cancer stem cells: functions and targeted inhibition for cancer therapy
Kamini Kaushal, Ainsley Mike Antao, Kye-Seong Kim, et al.
Drug Discovery Today (2018) Vol. 23, Iss. 12, pp. 1974-1982
Closed Access | Times Cited: 44
TGF-β signaling pathway mediated by deubiquitinating enzymes
Soo‐Yeon Kim, Kwang‐Hyun Baek
Cellular and Molecular Life Sciences (2018) Vol. 76, Iss. 4, pp. 653-665
Open Access | Times Cited: 44
USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2
Amanda Tomie Ouchida, Merve Kacal, Adi Zheng, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 502, Iss. 4, pp. 429-434
Closed Access | Times Cited: 38
The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics
Jinho Seo, Min Wook Kim, Kwang‐Hee Bae, et al.
Biochemical Pharmacology (2018) Vol. 162, pp. 21-40
Closed Access | Times Cited: 38
TRIB2 modulates proteasome function to reduce ubiquitin stability and protect liver cancer cells against oxidative stress
Susu Guo, Yuxin Chen, Yueyue Yang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis
Jiaqi Liu, Chi Tim LEUNG, Luyun Liang, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3547-3547
Open Access | Times Cited: 19
Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
Yi-Zheng Fang, Jiang Li, Qiaojun He, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 7, pp. 2955-2962
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top